February 24, 2009 (FinancialWire) -- Home Diagnostics, Inc. (NASDAQ: HDIX) has appointed Joseph H. Capper as president, CEO and director. The appointment concludes the executive search undertaken by the company's board last November to identify a replacement for J. Richard Damron, Jr., who served in the same capacity since 2001 and will be departing the company.

Capper was most recently president and CEO of CCS Medical, a medical supply management company, from 2003 to 2008. While in that role, he was responsible for acquiring and integrating Becton Dickenson's blood glucose monitoring division into the CCS product line and commercializing it under the Nova Max brand.

Prior to joining CCS, Capper worked with Bayer Healthcare's diabetes care division, where he served as the division's national sales director.

Fort Lauderdale, Florida-based Home Diagnostics is a developer, manufacturer and marketer of diabetes management solutions.

FinancialWire" ( http://www.financialwire.net ), an independent, proprietary news service of Investrend Communications, Inc., receives no compensation for its news or opinions. Further disclosure is at http://www.investrend.com/articles/secondlevel.asp?level=472 . To contact FinancialWire" write to inquiries@financialwire.net .

Free annual reports for companies mentioned in the news are accessible via http://investrend.ar.wilink.com/?level=279 .

Copyright(C)2009 by financialwire.net, Inc. All rights reserved.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.